Flight For Life Participates in Pre-hospital Tranexamic Acid (TXA) Study

Tranexamic Acid or TXA is an antifibrinolytic medication used to control bleeding in many clinical settings including traumatic brain injury (TBI).  Flight For Life is participating in The Pre-hospital Tranexamic Acid (TXA) Study to help determine if Tranexamic Acid (TXA), given in the pre-hospital setting, improves the long-term neurologic outcome in patients with TBI.

 

For more information on the TXA study, please click here:

 

http://www.mcw.edu/Emergency-Medicine/Research/Resuscitation/Milwaukee-ROC-TXA-Trial.htm

FFL - 09/22/2015